Bharat Biotech India Limited

Rediff.com » News » Bharat Biotech India Limited

News for Bharat Biotech India Limited

News
Business

Bharat Biotech's nasal vax priced at Rs 800 for private markets

Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......

Bharat Biotech to rectify issues with Covaxin raised by WHO

Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organisation regarding its COVID-19 vaccine -- Covaxin -- in a few days and added that the......

Bharat Biotech has two more Covid vaccines in pipeline

Today, the firm has delivered over four billion doses of vaccines and has over 140 patents under its belt. The company has in its portfolio over 16 vaccines and four bio-therapeutics, including......

'I'm willing to give more than Rs 35,000 crores for vaccines'

'I'll give it to the vaccine manufacturers without guarantees, take the payment in advance and give me the supplies.''The moment you give me one lot of supply, I'll give you more.' IMAGE: A......

'Few FCCB re-pay options for India Inc'

Only five Indian companies would be in a position to choose most available redemption options for their foreign currency convertible bonds (FCCBs), due for redemption this year, according to a......

Markets ended flat amid a volatile trading session

The markets ended flat amid a volatile trading session on Monday after elections for the 16th Lok Sabha kicked off today. Meanwhile, Sun Pharma and Ranbaxy Labs hogged the limelight after Sun......

PE not for small-ticket HNIs

Bharat Banka, Managing Directorand CEO, Aditya Birla Private Equity, is delighted with high net-worth individuals' rising interest in private equity. With expected returns of 25-30 per cent......

Pharmaceutical mega brand buyouts a sweet pill

Pharma giants are going the fast moving consumer goods way, with blockbuster brands being sought after by multinational giants and even their Indian peers.Universal Remedies, which sells the......

Rediff News

Bharat Biotech India Limited

News for Bharat Biotech India Limited

Bharat Biotech's nasal vax priced at Rs 800 for private markets

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Bharat Biotech to rectify issues with Covaxin raised by WHO

Bharat Biotech has two more Covid vaccines in pipeline

'I'm willing to give more than Rs 35,000 crores for vaccines'

'Few FCCB re-pay options for India Inc'

Markets ended flat amid a volatile trading session

PE not for small-ticket HNIs

Pharmaceutical mega brand buyouts a sweet pill

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS